Pharmacokinetics and Pharmacodynamics of MPA in Stable Renal Transplant Patients
|ClinicalTrials.gov Identifier: NCT00780429|
Recruitment Status : Unknown
Verified October 2008 by IRCCS Policlinico S. Matteo.
Recruitment status was: Active, not recruiting
First Posted : October 27, 2008
Last Update Posted : October 27, 2008
Study of the pharmacokinetic and pharmacodynamic variability of mycophenolate mofetil in renal transplant patients already on long-term MMF treatment (at least 6 months post-transplant; at least 3 months in therapy).
Study hypothesis: to investigate whether long-term MMF therapy alters IMPDH biological activity and if there are any correlations with the risk of AR.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||54 participants|
|Official Title:||Evaluation of Pharmacokinetic and Pharmacodynamic Parameters in Renal Transplant Patients Receiving Mycophenolic Acid and Stable for at Least 3 Months|
|Study Start Date :||June 2006|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00780429
|IRCCS Fondazione Policlinico San Matteo|
|Pavia, Italy, 27100|